2025年聚合酵素鏈鎖反應（PCR）分子診斷全球市場報告

預計聚合酵素鏈鎖反應(PCR) 分子診斷市場規模將在未來幾年強勁成長。到 2029 年，該市場規模將成長到 136.4 億美元，年複合成長率（CAGR）為 8.7%。預測期內的成長可歸因於癌症盛行率的上升、對個人化醫療的需求不斷成長、對分子診斷的投資不斷增加、對快速診斷測試的需求不斷成長以及對非侵入性產前檢測的需求不斷成長。在此期間，預期的主要趨勢包括診斷技術的進步、即時聚合酵素鏈鎖反應系統的開發、多重聚合酵素鏈鎖反應的創新、聚合酵素鏈鎖反應與微流體聚合酵素鏈鎖反應平台的技術增強。

感染疾病的日益普及預計將推動聚合酵素鏈鎖反應(PCR) 分子診斷市場的擴張。感染疾病是由細菌、病毒、真菌和寄生蟲等有害微生物引起的，可以透過人際直接或間接傳播。這些疾病的日益普及主要是由於抗生素抗藥性病原體的增多，這使得它們更難以治療和控制，導致病程延長、醫療成本上升和公共衛生風險增加。 PCR 分子診斷技術能夠在基因層面快速且準確地檢測病原體，從而改善感染疾病的管理，實現早期診斷和針對性治療。這透過促進及時介入、遏制感染傳播和改善患者照護來改善醫療保健結果。例如，2023年11月，美國政府機構衛生與公眾服務部報告稱，2022年新報告的慢性乙型肝炎病例與2021年相比增加了11%。因此，感染疾病盛行率的上升正在推動PCR分子診斷市場的成長。

聚合酵素鏈鎖反應(PCR) 分子診斷市場的主要企業正致力於開發桌上型儀器等尖端解決方案，以提高檢測效率和可及性。桌上型儀器是實驗室級儀器，體積小巧，可放置在工作台或桌子上，專為科學、醫療和工業測試與分析而設計。例如，2024 年 9 月，德國生物技術公司 QIAGEN NV 推出了用於臨床腫瘤學檢測的 QIAcuityDx 數位 PCR 系統。該系統將分區、熱循環和成像功能整合在一台儀器中，並具有全自動、無人值守處理功能。 DNA 和 RNA 的絕對定量分析可在大約兩小時內完成，且無需太多手動操作。該系統支援多達五個檢測通道，用於連接複用和順序奈米板加載，並透過提供檢驗且靈活的研究模式，可適應各種臨床和實驗室需求。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球聚合酵素鏈鎖反應（PCR）分子診斷PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球聚合酵素鏈鎖反應（PCR）分子診斷市場：成長率分析
• 全球聚合酵素鏈鎖反應（PCR）分子診斷市場表現：規模與成長，2019-2024年
• 全球聚合酵素鏈鎖反應(PCR) 分子診斷市場預測：規模與成長，2024-2029 年，2034 年
• 全球聚合酵素鏈鎖反應（PCR）分子診斷總目標市場（TAM）

第6章市場區隔

• 全球聚合酵素鏈鎖反應(PCR) 分子診斷市場（按產品類型、性能和預測）2019-2024 年、2024-2029 年、2034 年
• 裝置
• 試劑和耗材
• 軟體
• 全球聚合酵素鏈鎖反應(PCR) 分子診斷市場（按技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 即時聚合酵素鏈鎖反應
• 數位聚合酵素鏈鎖反應
• 常規聚合酵素鏈鎖反應
• 全球聚合酵素鏈鎖反應(PCR) 分子診斷市場（依樣本類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
• 血液樣本
• 唾液樣本
• 組織樣本
• 尿液樣本
• 全球聚合酵素鏈鎖反應（PCR）分子診斷市場的應用、效能及預測（2019-2024年、2024-2029年及2034年）
• 傳染病檢查
• 腫瘤學檢測
• 其他用途
• 全球聚合酵素鏈鎖反應(PCR) 分子診斷市場（依最終使用者、績效及預測），2019-2024 年、2024-2029 年及 2034 年
• 醫院
• 診斷實驗室
• 其他最終用戶
• 全球聚合酵素鏈鎖反應(PCR) 分子診斷市場、儀器、按類型細分：實際和預測，2019-2024 年、2024-2029 年、2034 年
• 標準聚合酵素鏈鎖反應系統
• 數聚合酵素鏈鎖反應系統
• 即時聚合酵素鏈鎖反應系統
• 全球聚合酵素鏈鎖反應(PCR) 分子診斷市場、試劑和耗材、按類型細分：實際和預測，2019-2024 年、2024-2029 年、2034 年
• 聚合酵素鏈鎖反應套件
• 聚合酵素鏈鎖反應酶
• 聚合酵素鏈鎖反應引子和探針
• 聚合酵素鏈鎖反應預混液
• 全球聚合酵素鏈鎖反應(PCR) 分子診斷市場、軟體、按類型細分：實際和預測，2019-2024 年、2024-2029 年、2034 年
• 聚合酵素鏈鎖反應分析軟體
• 資料管理軟體

第7章 區域和國家分析

• 全球聚合酵素鏈鎖反應（PCR）分子診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球聚合酵素鏈鎖反應(PCR) 分子診斷市場：依國家、表現及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 聚合酵素鏈鎖反應（PCR）分子診斷市場：競爭模式
• 聚合酵素鏈鎖反應（PCR）分子診斷市場：公司簡介
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Laboratory Corporation of America Holdings
• Agilent Technologies Inc.
• Grifols SA
• Illumina Inc.
• Endress+Hauser AG
• bioMereieux SA
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• QuidelOrtho Corporation
• PerkinElmer
• Eppendorf AG
• Tecan Group
• Takara Bio Inc.
• Biocartis NV
• Zymo Research Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029年聚合酵素鏈鎖反應（PCR）分子診斷市場：提供新機會的國家
• 2029年聚合酵素鏈鎖反應（PCR）分子診斷市場：細分領域帶來新機會
• 聚合酵素鏈鎖反應（PCR）分子診斷市場2029年：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

Polymerase chain reaction (PCR) molecular diagnostics is a laboratory method used to amplify and examine specific sequences of deoxyribonucleic acid or ribonucleic acid in a sample. Its primary function is to detect the presence of targeted genetic material, allowing for the identification of pathogens, genetic conditions, or mutations. This technique is extensively utilized in medical diagnostics due to its high sensitivity and accuracy in detecting infectious diseases, genetic disorders, and cancer-related markers.

The key product categories in PCR molecular diagnostics include instruments, reagents and consumables, and software. Instruments are devices or tools specifically designed for performing scientific, medical, or technical tasks and measurements. The technology includes real-time PCR, digital PCR, and conventional PCR methods, applied to various sample types such as blood, saliva, tissue, and urine. PCR molecular diagnostics are used across different applications, including infectious disease testing and oncology testing, and serve a range of end-users such as hospitals, diagnostic laboratories, and other healthcare facilities.

The polymerase chain reaction molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides polymerase chain reaction molecular diagnostics market statistics, including the polymerase chain reaction molecular diagnostics industry's global market size, regional shares, competitors with the polymerase chain reaction molecular diagnostics market share, detailed polymerase chain reaction molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reaction molecular diagnostics industry. This polymerase chain reaction molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The polymerase chain reaction molecular diagnostics market size has grown strongly in recent years. It will grow from $8.97 billion in 2024 to $9.78 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth during the historic period can be attributed to the rising demand for early disease detection, a growing prevalence of infectious diseases, heightened awareness of genetic disorders, increased adoption of point-of-care testing, and a higher incidence of chronic illnesses.

The polymerase chain reaction molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $13.64 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to the increasing prevalence of cancer, rising demand for personalized medicine, growing investments in molecular diagnostics, increasing need for rapid diagnostic tests, and expanding demand for non-invasive prenatal testing. Key trends expected during this period include advancements in diagnostic technologies, development of point-of-care polymerase chain reaction systems, innovations in multiplex polymerase chain reaction, integration of polymerase chain reaction with microfluidics, and technological enhancements in digital polymerase chain reaction platforms.

The growing prevalence of infectious diseases is expected to drive the expansion of the polymerase chain reaction (PCR) molecular diagnostics market. Infectious diseases are caused by harmful microorganisms, such as bacteria, viruses, fungi, or parasites, which can spread directly or indirectly from person to person. The increasing prevalence of these diseases is largely due to the rise of antibiotic-resistant pathogens, which are more difficult to treat and control, leading to prolonged illness, higher healthcare costs, and greater public health risks. PCR molecular diagnostics improve the management of infectious diseases by offering rapid and accurate pathogen detection at the genetic level, enabling early diagnosis and targeted treatment. This enhances healthcare outcomes by promoting timely interventions, reducing the spread of infections, and improving patient care. For example, in November 2023, the Department of Health and Human Services, a U.S. government agency, reported an 11% increase in newly reported chronic hepatitis B cases in 2022 compared to 2021. As a result, the rising prevalence of infectious diseases is fueling the growth of the PCR molecular diagnostics market.

Leading companies in the polymerase chain reaction (PCR) molecular diagnostics market are focusing on developing cutting-edge solutions, such as benchtop instruments, to improve testing efficiency and accessibility. Benchtop instruments are compact, laboratory-grade devices small enough to fit on a workbench or table, designed for scientific, medical, or industrial testing and analysis. For example, in September 2024, QIAGEN N.V., a Germany-based biotechnology company, introduced the QIAcuityDx Digital PCR System for clinical oncology testing. This system features fully automated, walk-away processing, integrating partitioning, thermocycling, and imaging into a single instrument. It provides absolute quantification of DNA and RNA in about two hours, with minimal hands-on time. The system supports up to five detection channels for multiplexing and continuous nanoplate loading, offering both validated and flexible research modes, making it adaptable to various clinical and laboratory requirements.

In May 2024, Bruker Corporation, a U.S.-based manufacturer of high-end analytical instruments, acquired ELITechGroup for $930.9 million. This acquisition allows Bruker to enhance its presence in infectious disease diagnostics by broadening its molecular diagnostic capabilities and product portfolio, enabling it to better serve clinical laboratories and hospitals worldwide. ELITech Group SAS is an Italy-based in-vitro diagnostics company, specializing in polymerase chain reaction (PCR) molecular diagnostics.

Major players in the polymerase chain reaction molecular diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Grifols S.A., Illumina Inc., Endress + Hauser AG, bioMereieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, and Zymo Research Corporation.

North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in polymerase chain reaction molecular diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the polymerase chain reaction molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The polymerase chain reaction molecular diagnostics market consists of revenues earned by entities by providing services such as infectious disease testing, genetic disorder screening, pharmacogenomics testing, deoxyribonucleic acid amplification services, and viral load monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The polymerase chain reaction molecular diagnostics market also includes sales of thermal cyclers, electrophoresis systems, assay kits, and reverse transcriptase enzymes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Polymerase Chain Reaction Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on polymerase chain reaction molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for polymerase chain reaction molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The polymerase chain reaction molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Instrument; Reagents And Consumables; Software
• 2) By Technology: Real-Time Polymerase Chain Reaction; Digital Polymerase Chain Reaction; Conventional Polymerase Chain Reaction
• 3) By Sample Type: Blood Samples; Saliva Samples; Tissue Samples; Urine Samples
• 4) By Application: Infectious Disease Testing; Oncology Testing; Other Applications
• 5) By End-User: Hospitals; Diagnostic Laboratories; Other End Users
• Subsegments:
• 1) By Instrument: Standard Polymerase Chain Reaction Systems; Digital Polymerase Chain Reaction Systems; Real-Time Polymerase Chain Reaction Systems
• 2) By Reagents And Consumables: Polymerase Chain Reaction Kits; Polymerase Chain Reaction Enzymes; Polymerase Chain Reaction Primers and Probes; Polymerase Chain Reaction Master Mix
• 3) By Software: Polymerase Chain Reaction Analysis Software; Data Management Software
• Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Polymerase Chain Reaction Molecular Diagnostics Market Characteristics

3. Polymerase Chain Reaction Molecular Diagnostics Market Trends And Strategies

4. Polymerase Chain Reaction Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Polymerase Chain Reaction Molecular Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Polymerase Chain Reaction Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Polymerase Chain Reaction Molecular Diagnostics Market Growth Rate Analysis
• 5.4. Global Polymerase Chain Reaction Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Polymerase Chain Reaction Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Polymerase Chain Reaction Molecular Diagnostics Total Addressable Market (TAM)

6. Polymerase Chain Reaction Molecular Diagnostics Market Segmentation

• 6.1. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instrument
• Reagents And Consumables
• Software
• 6.2. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Real-Time Polymerase Chain Reaction
• Digital Polymerase Chain Reaction
• Conventional Polymerase Chain Reaction
• 6.3. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Samples
• Saliva Samples
• Tissue Samples
• Urine Samples
• 6.4. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease Testing
• Oncology Testing
• Other Applications
• 6.5. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By EndUser, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Other End Users
• 6.6. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Polymerase Chain Reaction Systems
• Digital Polymerase Chain Reaction Systems
• Real-Time Polymerase Chain Reaction Systems
• 6.7. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction Kits
• Polymerase Chain Reaction Enzymes
• Polymerase Chain Reaction Primers And Probes
• Polymerase Chain Reaction Master Mix
• 6.8. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction Analysis Software
• Data Management Software

7. Polymerase Chain Reaction Molecular Diagnostics Market Regional And Country Analysis

• 7.1. Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market

• 8.1. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Polymerase Chain Reaction Molecular Diagnostics Market

• 9.1. China Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 9.2. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Polymerase Chain Reaction Molecular Diagnostics Market

• 10.1. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Polymerase Chain Reaction Molecular Diagnostics Market

• 11.1. Japan Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 11.2. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Polymerase Chain Reaction Molecular Diagnostics Market

• 12.1. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market

• 13.1. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Polymerase Chain Reaction Molecular Diagnostics Market

• 14.1. South Korea Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 14.2. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market

• 15.1. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 15.2. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Polymerase Chain Reaction Molecular Diagnostics Market

• 16.1. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Polymerase Chain Reaction Molecular Diagnostics Market

• 17.1. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Polymerase Chain Reaction Molecular Diagnostics Market

• 18.1. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Polymerase Chain Reaction Molecular Diagnostics Market

• 19.1. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Polymerase Chain Reaction Molecular Diagnostics Market

• 20.1. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market

• 21.1. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 21.2. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Polymerase Chain Reaction Molecular Diagnostics Market

• 22.1. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Polymerase Chain Reaction Molecular Diagnostics Market

• 23.1. North America Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 23.2. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Polymerase Chain Reaction Molecular Diagnostics Market

• 24.1. USA Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 24.2. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Polymerase Chain Reaction Molecular Diagnostics Market

• 25.1. Canada Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 25.2. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Polymerase Chain Reaction Molecular Diagnostics Market

• 26.1. South America Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 26.2. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Polymerase Chain Reaction Molecular Diagnostics Market

• 27.1. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Polymerase Chain Reaction Molecular Diagnostics Market

• 28.1. Middle East Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 28.2. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Polymerase Chain Reaction Molecular Diagnostics Market

• 29.1. Africa Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 29.2. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Polymerase Chain Reaction Molecular Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Polymerase Chain Reaction Molecular Diagnostics Market Competitive Landscape
• 30.2. Polymerase Chain Reaction Molecular Diagnostics Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Polymerase Chain Reaction Molecular Diagnostics Market Other Major And Innovative Companies

• 31.1. Laboratory Corporation of America Holdings
• 31.2. Agilent Technologies Inc.
• 31.3. Grifols S.A.
• 31.4. Illumina Inc.
• 31.5. Endress + Hauser AG
• 31.6. bioMereieux SA
• 31.7. Sysmex Corporation
• 31.8. Bio-Rad Laboratories Inc.
• 31.9. QuidelOrtho Corporation
• 31.10. PerkinElmer
• 31.11. Eppendorf AG
• 31.12. Tecan Group
• 31.13. Takara Bio Inc.
• 31.14. Biocartis NV
• 31.15. Zymo Research Corporation

32. Global Polymerase Chain Reaction Molecular Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Polymerase Chain Reaction Molecular Diagnostics Market

34. Recent Developments In The Polymerase Chain Reaction Molecular Diagnostics Market

35. Polymerase Chain Reaction Molecular Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer